Skip to content

Source filing unavailable

Q3 2011 · —
Revenue$202.19M+8.3% vs Q3 2010+4.6% vs Q2 2011
Net Income$11.24M−31.8% vs Q3 2010+1,508.4% vs Q2 2011
EPS Diluted$0.39−29.1% vs Q3 2010+1,850.0% vs Q2 2011
Gross Profit$123,534,000+5.2%
Operating Income$18,291,000−33.0%
Operating Cash Flowderived$23,795,000−19.7%
Free Cash Flowderived$11,552,000−48.5%
Margins · derived
Gross margin61.1%−1.8 pt vs Q3 2010
Operating margin9.0%−5.6 pt vs Q3 2010
Net margin5.6%−3.3 pt vs Q3 2010

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ3 2011Q3 2010Q3 2009
Revenue$202.19M$186.64M$172.29M
Net Income$11.24M$16.48M$14.43M
EPS Diluted$0.39$0.55$0.49

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Integra Lifesciences Holdings Corp · CIK 917520 · Engraved from SEC EDGAR